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Objectives: The diaphragm, a woman controlled, reusable contraceptive device, might prevent some
sexually transmitted infections (STIs). We assessed the acceptability and feasibility of use of silicone Wide-
Seal Arcing Diaphragms (Milex Products, Chicago, IL, USA) by sex workers in Madagascar.
Methods: Over 8 weeks, we evaluated method acceptability by examining patterns of and problems with
women’s diaphragm use. We also evaluated several measures of study feasibility, including recruitment
and follow up methods.
Results: 91 women from three cities (Antananarivo, Tamatave, and Mahajanga) participated, and 87
(96%) completed follow up. At enrolment, participants reported a median of six sex acts with five clients in
the previous week. During the follow up period, participants reported a median of three sex acts with three
clients during the previous 2 days, and self reported continuous diaphragm use during the previous day
increased from 87% to 93%. Seven women became pregnant (incidence 53 pregnancies per 100 woman
years). Self reported use of male condoms and diaphragms was fairly constant over the study period:
women reported condom use in 61% to 70% of acts and diaphragms in 95% to 97% of acts. The number of
participants reporting diaphragm problems decreased from 15 (16%) at the first visit to six (7%) at the final
visit. 20 women (22%) needed replacement devices during follow up because their original diaphragms
were lost, were the wrong size, or became seriously damaged.
Conclusions: Given the high use and steady decrease in reported problems during the study, we believe
diaphragms are acceptable and feasible in this resource poor, low education sex worker population.
B
ecause many women lack the social and economic power
to insist that their sex partners remain monogamous or
use condoms, millions remain vulnerable to sexually
transmitted infections (STIs). For years researchers have
discussed the need for women controlled STI prevention
options that could be used without men’s permission or even
knowledge.1 The diaphragm, a reusable contraceptive device
approved worldwide for prevention of pregnancy,2 has
attracted renewed attention as a means to control STIs and
HIV.3–5 By covering the cervix during exposure to gonorrhoea,
chlamydia, or HIV (and possibly other STIs), diaphragms
may block these pathogens from reaching their preferred
infection site. Diaphragms have a proved safety record
because of their long history as birth control, and they may
also be used clandestinely when partners reject male
condoms. While no yet published randomised trials have
evaluated the effectiveness of the diaphragm against STI
acquisition, several observational studies report a protective
effect of diaphragm use against gonococcal and chlamydial
infection and their long term sequelae.6–10
This study was conducted in Madagascar, a country with
both high STI rates and ample evidence that current
strategies for STI prevention are inadequate. In 1997, among
women who reported not trading sex for money who
presented with genitourinary symptoms in the capital
Antananarivo, the prevalence of gonorrhoea and chlamydia
was 9.7% and 8.9%, respectively.11 In 2001, 75–78% of
asymptomatic female sex workers in Madagascar had at
least one curable STI, and up to 30% had gonorrhoea or
chlamydia.12 Rates remained high even after presumptive
treatment and condom promotion.12 Development of new STI
control methods is a crucial research priority, both to directly
reduce the STI burden and because STIs are likely to increase
risk of HIV acquisition.13–15
We plan to conduct a randomised trial to evaluate the
effectiveness of the diaphragm against Chlamydia trachomatis
and Neisseria gonorrhoeae in female sex workers in
Madagascar, and we completed the 8 week pilot study
described here to assess the acceptability and feasibility of
diaphragm use in this population. In addition to measuring
changes in diaphragm and condom use patterns, problems
with study products, and reasons for discontinuation, we also
assessed several study design components such as recruit-
ment and follow up methods. Formative research on
acceptability and feasibility was particularly appropriate
because diaphragms are virtually unknown in Madagascar.
METHODS
We recruited women who self identified as sex workers in
three urban centres in Madagascar (Antananarivo, Tamatave,
and Mahajanga). National STI treatment guidelines in
Madagascar recommend that all sex workers be seen
quarterly at government health clinics for routine STI testing
and treatment, although compliance is voluntary and no
formal sex worker registry exists. Peer counsellors recruited
participants from clinics when they presented for their STI
visits. Eligible women were inconsistent condom users
(reporting less than 100% condom use with clients in the
past month), not pregnant or desiring pregnancy in the next
6 months, with healthy vagina and cervix upon visual
inspection, and able to be fitted with a diaphragm. We
followed women for 8 weeks.
Women provided written informed consent before screen-
ing, and eligible participants signed a second consent form at
enrolment. The institutional review board at the University of
Abbreviations: EC, emergency contraception; RPR, rapid plasma
reagin; STI, sexually transmitted infections; UTI, urinary tract infection
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North Carolina at Chapel Hill and the Comité d’Ethique
auprès du Ministère de la Santé in Madagascar approved the
study.
At screening, participants received pelvic examinations to
assess clinical signs of vaginitis and cervicitis, urinalysis (to
evaluate leucocytes in urine) to screen for urinary tract
infection (UTI) (Multistix 10 SG Reagent Strips for
Urinalysis, Bayer Corporation, IN, USA), urine dipstick for
pregnancy testing (Clearview hCG Combo, Wampole
Laboratories, NJ, USA), and blood testing for syphilis (BD
Macro-Vue RPR Card Tests, Becton, Dickinson and Company,
MD, USA). All women with symptoms suggestive of UTI and
positive urine test received UTI treatment. Women with
genital ulcers were treated according to Madagascar’s
national guidelines.12
Women deemed eligible at screening were enrolled
immediately. Staff administered structured questionnaires
capturing participants’ health and behavioural characteris-
tics, sexual history, contraception, and condom use. We
dispensed presumptive treatment for gonococcal and chla-
mydial infections to all women (500 mg ciprofloxacin and 1 g
azithromycin) and then 1 week later, at the first follow up
visit, for bacterial vaginosis and trichomoniasis (2 g metro-
nidazole).
Study clinicians fitted each woman for a diaphragm
according to standard clinical guidelines, selecting the largest
size that was comfortable to the participant and remained
properly placed with valsalva. Clinicians verified that women
could correctly insert and withdraw their diaphragms and
provided extensive instructions about method use, cleaning
and storage.
Women were instructed to wear the diaphragm at all
times, removing it once daily for cleaning and for bathing or
vaginal hygiene, then immediately replacing it (‘‘continuous
use’’). Lubricant gel was not provided and its use was not
encouraged. We instructed women to remove the device only
when at least 6 hours had passed since the last sex act, and to
leave it in place for removal by clinicians on visit days. (If
fewer than 6 hours had passed since the last sex act when
women returned for follow up visits, clinicians did not
remove the diaphragm and the examination was resched-
uled). We told women that diaphragms were developed for
contraception, but that they do not provide adequate
pregnancy protection without spermicide. Participants were
also given information about emergency contraception (EC)
and told that if they had unprotected sex and wanted to
reduce the risk of pregnancy, they could purchase discounted
EC for $1 from the clinic. We told women that the diaphragm
was not known to protect against STIs.
At each follow up visit (1, 2, and 8 weeks after enrolment),
women were interviewed to assess problems with and
changes in diaphragm and condom use. To improve recall,
we asked only about sexual practices over the previous
2 days. At the 1 week visit, those women who were
seropositive for syphilis at enrolment were treated following
the national guidelines (three doses of 2.4 MIU benzathine
penicillin at 1 week intervals).12 UTI screening was performed
at each visit; UTI treatment (100 mg nitroxocine, three times
daily for 8 days) was dispensed to symptomatic women who
had leucocytes in their urine. Pregnancy testing was repeated
at 4 weeks and 8 weeks.
We gave each woman a silicone Wide-Seal Arcing
Diaphragm (Milex Products, Chicago, IL, USA), and as many
male condoms as they wanted (spermicide free Protector Plus
latex condoms). All women received safer sex counselling
and were instructed to use condoms with every sex act.
Using the total number of reported sex acts as the offset
variable, Poisson regression models were run to generate the
Table 1 Demographic and reproductive characteristics of study participants at enrolment
Characteristic
Antananarivo (n = 30) Tamatave (n = 31) Mahajanga (n = 30) Total (n = 91)
Median (range) Median (range) Median (range) Median (range)
Age 27 (18–42) 25 (20–45) 29.5 (18–48) 28 (18–48)
Number of pregnancies 2.5 (0–7) 2 (0–6) 2 (0–5) 2 (0–7)
Completed years of schooling 4 (0–8) 5 (0–11) 5 (0–13) 5 (0–13)
Number of sex acts, last week 11 (0–27) 4 (0–32) 7 (0–40) 6 (0–40)
Number of sex partners, last week 10 (0–26) 3 (0–32) 6 (0–40) 5 (0–40)
Number of new sex partners, last week 1 (0–13) 3 (0–32) 3 (0–34) 3 (0–34)
No (%) No (%) No (%) No (%)
Occupation
None 20 (67) 13 (42) 24 (80) 57 (63)
Trade/commerce 3 (10) 8 (26) 3 (10) 14 (15)
Professional 0 (0) 1 (3) 0 (0) 1 (1)
Domestic 0 (0) 9 (29) 1 (3) 10 (11)
Other 7 (23) 0 (0) 2 (7) 9 (10)
Current contraceptive method
None 18 (60) 23 (74) 7 (23) 48 (53)
Oral 1 (3) 6 (19) 3 (10) 10 (11)
Injectable 4 (13) 2 (6) 6 (20) 12 (13)
Condom 7 (23) 0 (0) 13 (43) 20 (22)
Other 0 (0) 0 (0) 1 (3) 1 (1)
Used condom at last vaginal sex 22 (73) 23 (74) 13 (43) 58 (64)
Ever genital ulcer 9 (30) 11 (35) 14 (47) 34 (37)
Ever oral sex 5 (17) 3 (10) 1 (3) 9 (10)































Figure 1 Percentage and 95% confidence intervals of sex acts
protected by male condoms or diaphragms at enrolment and follow up
visits.* (*The enrolment questionnaire asked about use of condoms over
the past week; the follow up questionnaire asked about condom and
diaphragm use over the past 2 days.)
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proportion of sex acts protected by condoms and diaphragms
at each study visit. We analysed the data using SAS (SAS
Institute, Version 9.1, Cary, NC, USA).
RESULTS
The study took place from April through July 2004. All
women (n=97) approached by study staff agreed to be
screened (100% response rate). Ninety one women met the
inclusion criteria and were enrolled: 30 in Antananarivo, 31
in Tamatave, and 30 in Mahajanga; 87 participants (96%)
were followed for the 8 week study duration.
Table 1 describes baseline demographic characteristics of
enrolled women. Participants’ median age was 28 years
(range 18–48). They had completed a median of 5 years of
education. The majority (84%) were unmarried and not living
with partners. Most (63%) reported no occupation, though
some were domestic workers (11%), and others worked in
trade (15%). More than half (53%) reported no contraceptive
method, while 13% used injectables and another 11% took
oral contraceptives. Twenty women (22%) used condoms for
contraception.
At enrolment, participants reported on their sexual
behaviour over the previous week. Women had a median of
six sex acts (range 0–40) with five clients (range 0–40)
(table 1). Nearly two thirds (64%) said they had used
condoms during their last sex act. More than one third (37%)
reported a history of genital ulcers. Twenty five participants
(27%) were rapid plasma reagin (RPR) seroreactive, and
three (3%) had both UTI symptoms and leucocytes in their
urine.
The median diaphragm size dispensed at enrolment was
70 mm, and the modal size was 65 mm (range 60–80 mm);
95% of devices were between 65 mm and 75 mm.
Trends in condom and diaphragm use are shown in table 2
and figure 1. At follow up, women answered questions about
their sexual behaviour over the previous 2 days (compared
with enrolment, where sexual behaviour was assessed over
the previous week). Reported condom use remained roughly
constant, increasing slightly from 61% of acts protected by
condoms at enrolment, to 65% at the 1 week visit and 70% at
the 4 week visit, decreasing slightly to 67% at the final visit
(fig 1). Diaphragm use was also fairly constant: diaphragms
were used in 97% of acts at 1 week, unchanged at 4 weeks,
and 95% of acts at the 8 week visit. Condom failure (when a
condom slipped off or ruptured) in the past week was
common, reported by four women at the 1 week and 4 week
follow up visits and 10 women at the final visit.
We also computed the absolute number (rather than
proportion) of unprotected sex acts, where condoms or
diaphragms were not used. The number of women reporting
zero unprotected acts (in other words, that all acts were
protected by condoms, either alone or together with the
diaphragm), stayed approximately the same over time. At
enrolment, 30 women (42%) reported they used condoms at
all sex acts; at both the 1 week and 4 week visits, 39% of
women reported they used condoms at all sex acts. At the
final visit, 35 women (48%) reported always using condoms.
Conversely, the number of women reporting four or more sex
acts without condoms decreased and then stabilised.
Eighteen women (25%) at enrolment reported four or more
sex acts where condoms were not used, compared with seven
participants (9%) at the 1 week visit and five participants
(6%) at the 4 week visit. At the final visit, eight women
(11%) reported four or more sex acts without condoms.
We also assessed the absolute number of sex acts where
women used diaphragms, either alone or together with
condoms (table 2). In general, reported diaphragm use was
high, with 67 women (89%) at the 1 week visit, 67 women
(87%) at the 4 week visit, and 69 women (95%) at the 8 week
visit reporting they used their diaphragm at all sex acts.
During the 8 week period, only one woman reported having
sex four or more times without the diaphragm.
One third of participants (n=31) reported problems
involving 33 diaphragms during the study. Most were minor,
such as discoloration or slight variations in shape. Eight
diaphragms sustained major damage, including five when
participants folded them at an inflexible part of the device
rim. Twenty replacement diaphragms were dispensed,
because five original devices were the wrong size, seven
had been lost, and eight were seriously damaged.
Seven women became pregnant: five pregnancies were
diagnosed at the 4 week visit and two additional pregnancies
at the final visit. Because we tested for pregnancy at
enrolment and not again until the 4 week visit, some women
found to be pregnant at 4 weeks may have already been
pregnant (though not clinically detectable) at enrolment. If
all seven women truly became pregnant during their
participation, the incidence rate is 53 pregnancies per 100
women years (exact 95% confidence interval: 21 to 110
pregnancies per 100 woman years). No women requested EC
during the study.
Participant reports of vaginal discharge and pelvic tender-
ness increased when diaphragms were initially dispensed,
but returned to enrolment levels by the study’s conclusion
(table 3). Incident UTIs remained low at all visits and no
women experienced repeat UTIs during the study. Clinical
abnormalities on the vulva, vagina, cervix, uterus, and
adnexes were also rare (maximum 9% at any visit). No
women were discontinued early because of protocol viola-
tions.
Table 2 Participants’ reported sexual frequency, condom and diaphragm use by study visit*
Enrolment (n = 72) 1 week visit (n = 75) 4 week visit (n = 77) 8 week visit (n = 73)
Median (range) Median (range) Median (range) Median (range)
Number of sex acts 6 (0–40) 3 (0–26) 3 (0–26) 3 (0–32)
No (%) No (%) No (%) No (%)
Women reporting sex acts where condoms were not used`
0 acts 30 (42) 29 (39) 30 (39) 35 (48)
1–3 acts 24 (33) 39 (52) 42 (55) 30 (41)
4 or more acts 18 (25) 7 (9) 5 (6) 8 (11)
Women reporting sex acts where diaphragms were not used`
0 acts – – 67 (89) 67 (87) 69 (95)
1–3 acts – – 8 (11) 10 (13) 3 (4)
4 or more acts – – 0 (0) 0 (0) 1 (1)
*At enrolment women reported how many times they had sex and their use of condoms in the last week. At follow up visits, women reported how many times they
had sex and their use of condoms and diaphragms in the last 2 days.
At enrolment, tallies refer to sex acts protected by condoms alone.
`Only among women reporting any sex acts.
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Continuous diaphragm use appeared highly acceptable:
reported continuous use for the previous day increased from
87% at the 1 week visit to 93% at the 8 week visit. In
addition, the number of women reporting diaphragm
problems decreased from 15 participants (16%) at the 1 week
visit to six (7%) at the final visit. Early in the study,
participants’ complaints included physical issues such as
discomfort and awareness of the diaphragm by a partner
during sex. Nearer the study end, problems focused on lost or
damaged devices. Focus group discussions with these women
also explored diaphragm acceptability, including women’s
opinions about use and whether they would recommend the
diaphragm to friends (an analysis of these discussions is
forthcoming).
Fifty one adverse events (including self reported events
and those noted during clinical exams) were reported in 29
women. Nearly two thirds (65%) were related to gynaecolo-
gical symptoms such as vaginal discharge or itching (n=14),
genital ulcers (n=8, three identified as probable herpes),
dysuria (n=3), proteinuria (n=3), leucocyturia (n=2), and
cervicitis (n=3); most others (31%) related to gastrointest-
inal or influenza-like illness. No serious adverse events were
reported.
DISCUSSION
Diaphragms were highly acceptable among these study
participants. Our acceptability measures included the propor-
tion of women reporting using diaphragms continuously
during the previous day (ranged by follow up visit from 88%
to 93%), high retention (96%), and low occurrence of product
non-use. Problems decreased during the study, suggesting
that women became more comfortable with their diaphragms
over time and thus had fewer negative experiences.
We conclude that a trial of diaphragm use in this
population is highly feasible. Possibly because of our work
over several years with sex worker populations in
Madagascar, we had a response rate of 100% and recruited
our desired sample size quickly. In addition, our tracking and
contact methods allowed us to follow 96% of participants
successfully.
The study’s primary limitation is the short duration of
follow up. We are unable to generalise about diaphragm use
over a long period of time based on these data; we will
carefully measure patterns of diaphragm and condom use in
the randomised trial. Nevertheless, we monitored changes in
reported condom use to determine whether owning a
diaphragm was associated with reduced condom use, since
condom migration during the planned randomised trial
would pose problems for both ethical and methodological
reasons. We observed only minimal changes in condom use
in this small sample. In addition, although condom use did
not change substantially during follow up, the number of
women reporting that all sex acts were protected by condoms
was higher at the final visit than at any previous visit. We
acknowledge, however, that social desirability bias cannot be
ruled out. The results of focus group discussions may provide
more insight about women’s attitudes towards condom use.
It is possible that rates of diaphragm use, though quite
high during this short follow up period, will eventually fall to
those reported for condom use, since both are barrier
methods. Nevertheless, we are hopeful that the other
attributes of the diaphragm—that it is female controlled,
and may be used covertly and continuously—may allow for
higher usage rates over time.
We anticipated that participants’ generally low level of
schooling would necessitate extensive diaphragm education.
For example, leaving the diaphragm in place for at least
6 hours after sex was difficult for women who lack watches.
In other settings, new diaphragm users may be told that if
they have sex before going to sleep, they should leave the
device in place until they wake up the following morning.
Because of sex workers’ irregular hours, however, other
strategies for estimating time since the last sex act are
needed. Describing genital anatomy in simple terms was
another challenge, and it was necessary to dispel common
misconceptions about diaphragm use (for example, some
women believed that when they urinated the device would
fall out).
The pregnancy rate, 53 pregnancies per 100 women years,
is substantially higher than the rates of 11–13 pregnancies
per 100 women years reported in trials evaluating the
contraceptive efficacy of latex diaphragms plus spermicide.16
This finding is even more surprising considering that 24% of
women reported using oral or injectable hormonal contra-
ception at enrolment (including two of the women who
eventually became pregnant). Women’s non-use of EC may
indicate that participants did not fully understand the
diaphragm’s limited contraceptive efficacy or their risk of
pregnancy. Anecdotal evidence suggests that women are not
familiar with EC in Madagascar, so even though clinicians
discussed EC with participants, some may have remained
hesitant about using it. In addition, EC was not free, which
may have been a barrier to use. Other potential explanations
for the high pregnancy rate include possible misuse of the
diaphragm (such as not leaving it in for at least 6 hours after
sex) and misreporting the frequency or consistency of use of
diaphragms, condoms, or other contraceptive methods.
Finally, sex workers’ attitudes towards pregnancy are not
well understood, and some pregnancies may have been
desired if not planned. Pregnancy prevention in the
randomised trial will be addressed in greater detail in light
of these findings, and we will offer free hormonal contra-
ception to all participants.
An unexpected number of diaphragms were damaged
during the short follow up period. This particular diaphragm














No % No % No % No % No % No %
Enrolment (n = 91) 7 8 2 2 0 0 3 3 – – – –
1 week (n = 91 19 21 6 7 Not tested 3 3 80 88 76 84
4 week (n = 89) 16 18 6 7 5 6 2 2 82 92 82 92
8 week (n = 87) 7 8 8 9 6 7 0 0 81 93 77 89
*During physical examination, on vulva, vagina, cervix, uterus, and adnexa.
A negative pregnancy test at enrolment was a requirement for study participation. The six positive pregnancies at the 8 week follow up visit include four of the five
pregnancies diagnosed at the 4 week follow up visit, plus two additional pregnancies. A total of seven pregnancies occurred during the 8 week study period.
`UTI was considered positive if women reported symptoms suggestive of infection and had a positive dipstick result for leucocytes in urine.
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product, the Wide-Seal Arcing Diaphragm, has arrows
marked on the rim to indicate the appropriate place to fold
the device before insertion. Milex Products conducted an
analysis of all devices after the study to determine whether
the damage was the result of improper use or a manufactur-
ing error; they concluded that much of the damage occurred
in devices which became deformed when participants forced
them to fold at an inflexible place. To avoid similar damage in
the randomised study, we will use a diaphragm with an
‘‘Omniflex’’ design, which may be folded in any place along
the rim.
This study reinforces the need for woman controlled
methods of disease prevention. During the 8 week period,
17 participants, or almost one in five women, reported that a
condom had slipped off or ruptured at least once within the
past week. Thus, although many sex workers reported using
condoms, this method is far from failsafe. The availability of
an additional method of STI prevention may prove highly
valuable to millions of vulnerable women worldwide.
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Key messages
N In regions where incidence of sexually transmitted
infections (STI) is high and women lack the social and
economic power to insist that their partners remain
monogamous or use condoms, new ‘‘women con-
trolled’’ methods for disease prevention are very much
needed. The diaphragm, a reusable contraceptive
device approved worldwide for prevention of preg-
nancy, may be an effective option for control of some
STIs
N Continuous diaphragm use, without lubricant or
spermicide, was acceptable and feasible in a resource
poor, low education sex worker population
N According to self reports, women’s use of condoms did
not decline when they began using diaphragms; in
addition, diaphragm use was very high throughout
follow up (diaphragms used in 95%–97% of sex acts)
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